Changes in Magnesium and Potassium Homeostasis after Conversion from a Calcineurin Inhibitor Regimen to an mTOR Inhibitor-Based Regimen.

被引：0
|
作者：
Sanchez-Fructuoso, A. I. [1 ]
Santin Cantero, J. M. [1 ]
Perez-Flores, I. [1 ]
Calvo, N. [1 ]
Valero, R. [1 ]
Matilla, E. [1 ]
Vilalta, R. [2 ]
Barrientos, A. [1 ]
机构：
[1] Hosp Clin Univ San Carlos, Madrid, Spain
[2] Hosp Gen Valle Hebron, Pediat Nephrol Dept, Barcelona, Spain
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
979
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [1] Changes in Magnesium and Potassium Homeostasis after Conversion from a Calcineurin Inhibitor Regimen to an mTOR Inhibitor-Based Regimen
    Sanchez-Fructuoso, A. I.
    Santin Cantero, J. M.
    Perez Flores, I.
    Valero San Cecilio, R.
    Calvo Romero, N.
    Vilalta Casas, R.
    [J]. TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) : 3047 - 3049
  • [2] DOSING RATIONALE OF BELATACEPT IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS SWITCHING FROM CALCINEURIN INHIBITOR-BASED REGIMEN.
    Lee, S.
    Zhou, Z.
    Roy, A.
    Jones-Burton, C.
    Harler, M.
    Shen, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S75 - S75
  • [3] Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: Effect on renal function and proteinuria
    Morales, J.
    Fierro, A.
    Benavente, D.
    Zehnder, C.
    Ferrario, M.
    Contreras, L.
    Herzog, C.
    Buckel, E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (03) : 591 - 593
  • [4] Impact of Calcineurin-Inhibitor Conversion to mTOR Inhibitor on Renal Allograft Function in a Prednisone-Free Regimen
    Chhabra, D.
    Alvarado, A.
    Dalal, P.
    Leventhal, J.
    Wang, C.
    Sustento-Reodica, N.
    Najafian, N.
    Skaro, A.
    Levitsky, J.
    Mas, V.
    Gallon, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (11) : 2902 - 2911
  • [5] Additional Everolimus Minimize Calcineurin Inhibitor Exposure in Corticosteroid Minimization/Early Withdrawal Regimen.
    Harada, H.
    Fukuzawa, N.
    Maehana, T.
    Higuchi, H.
    Chiba, S.
    Kawaguchi, A.
    Nakamura, M.
    Tanaka, H.
    Hirano, T.
    Seki, T.
    Togashi, M.
    [J]. TRANSPLANTATION, 2014, 98 : 547 - 547
  • [6] Considerations on the effectiveness of nevirapine in protease inhibitor-based regimen simplification
    Martinez, Esteban
    Gatell, Jose M.
    [J]. AIDS, 2007, 21 (13) : 1829 - 1830
  • [7] Conversion to a calcineurin inhibitor (CI) and steroid free regimen after pancreas (Px) transplantation (Tx).
    Gruessner, R
    Humar, A
    Kandaswamy, R
    Gruessner, A
    Sutherland, D
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 561 - 561
  • [8] HIV integrase inhibitor-based regimen beats market leader
    Sarah Crunkhorn
    [J]. Nature Reviews Drug Discovery, 2012, 11 : 664 - 664
  • [9] DETERMINANTS OF PROTEINURIA AFTER CONVERSION FROM A CALCINEURIN INHIBITOR- TO SIROLIMUS-BASED IMMUNOSUPPRESSIVE REGIMEN: RESULTS FROM THE CONVERT TRIAL
    Pussell, B.
    Russ, G.
    Walker, R.
    O'Connell, P.
    Kanellis, J.
    Eris, J.
    [J]. NEPHROLOGY, 2006, 11 : A21 - A22
  • [10] Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients: A Randomized Phase II Study
    Rostaing, Lionel
    Massari, Pablo
    Garcia, Valter Duro
    Mancilla-Urrea, Eduardo
    Nainan, Georgy
    del Carmen Rial, Maria
    Steinberg, Steven
    Vincenti, Flavio
    Shi, Rebecca
    Di Russo, Greg
    Thomas, Dolca
    Grinyo, Josep
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (02): : 430 - 439
12345